Loading chat...
FL S1602
Bill
AI Summary
- Creates Section 385.2021, Florida Statutes to establish framework for reimbursement programs in cancer clinical trials
- Requires cancer clinical trial programs to inform prospective participants that reimbursement for travel and ancillary costs is available based on financial need and available to caregivers
- Specifies that reimbursement offers for travel and ancillary costs are not inducements for participation if they are not coercive or exert undue influence
- Authorizes corporations, individuals, foundations, health care providers, and other stakeholders to offer financial support through third-party nonprofit corporations and public charities for patient and caregiver reimbursement
- Requires patient subjects to submit signed informed consent statement acknowledging financial eligibility guidelines and reimbursement process before participating in cancer clinical trials
- Mandates Department of Health review and approval of reimbursement programs based on fair recruitment, adequate participant information, and appropriateness of covered expenses
- Effective date: July 1, 2019
Legislative Description
Cancer Clinical Trials
Last Action
Died in Health Policy
5/3/2019
Committee Referrals
Health Policy3/8/2019
Full Bill Text
No bill text available